Citations

Citations to this article as recorded by  

• Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
  Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
  Journal of Diabetes Science and Technology.2026; 20(3): 775.     CrossRef
• Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
  Ji Yoon Kim, Hye‐Min Jang, Hye‐Jin Lee, Ah Hyeon Lee, Dong‐Hoon Kim, Sin Gon Kim, Nam Hoon Kim
  Diabetes, Obesity and Metabolism.2026; 28(3): 1764.     CrossRef
• Development and Validation of a High‐Performance Liquid Chromatography Coupled With Photodiode Array Detection Method for the Simultaneous Analysis of Metformin, Cyanoguanidine, and Antidiabetic Agents in Fixed‐Dose Combinations
  Gökhan Bayrak, Selen Al, Aykut Kul, Armağan Önal
  SEPARATION SCIENCE PLUS.2026;[Epub]     CrossRef
• Ethnic Disparities in Glycemic Control among Malaysian Adults with Type 2 Diabetes: A Retrospective Multivariable Analysis
  Fikry Ahmad, Suhaili Abubakar, Sharifah Sakinah Syed Alwi, Ng Ooi Chuan, Hasni Idayu Saidi
  Journal of Racial and Ethnic Health Disparities.2026;[Epub]     CrossRef
• GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes
  Kunal Zaveri, Girish Kulkarni, Rathish Nair, Govarthanan Shanmugan, Shubhada Amol Dharmadhikari, R. P. S. Makkar, Rahul Jalgaonkar, B. D. Chatterjee, Krishnaprasad Korukonda, Natural Hoi Sing Chu
  PLOS One.2026; 21(2): e0337107.     CrossRef
• A Randomized, Multicenter Study Evaluating the Efficacy, Safety and Tolerability of Dapagliflozin + Gliclazide Fixed Dose Combination Over Dapagliflozin Monotherapy in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin Monotherapy
  Suhas G Erande, Amar Raykantiwar, Vivek Shejole, Rashmi GR, Animesh Maiti, A.S. Veeramani Kartheek, Mohamed Hanifah, Richa Giri, Sharvil Gadve, Arindam Ray, Kunal Thakkar, Balram Sharma, Saket Kant, Abhyudaya Verma , Yogesh Yadav, Hiren Prajapati, Honey D
  Cureus.2026;[Epub]     CrossRef
• Comparative Analysis of Clinical Outcomes in Patients With Type 2 Diabetes Mellitus on Monotherapy Versus Combination Therapy
  Hariballav Mahapatra, Piyush Kumar Gupta, Ajo Paul, Amit Nampalliwar, Manju Bansal, Baijnath Das, K. Parameswaran Namboothiri
  Cureus.2026;[Epub]     CrossRef
• Clinical Experience and Outcomes with Triple-drug Fixed-dose Combination Therapy (Sitagliptin + Dapagliflozin + Metformin Sustained-Release Tablets) in Type 2 Diabetes Mellitus Management: A Real-world Observational Survey of Clinician Perspectives
  Manoj Arajanbhai Suva
  Archives of Medicine and Health Sciences.2026; 14(1): 61.     CrossRef
• Circulating GDF15 levels reflect metabolic and inflammatory burden in early dysglycemia: findings from the ADIOS cohort
  Ji Yoon Kim, Ah Hyeon Lee, Jiyoon Lee, Hye-Min Jang, Sin Gon Kim, Dong-Hoon Kim, Nam Hoon Kim
  Diabetes Research and Clinical Practice.2026; 239: 113461.     CrossRef
• A Phase III, Randomized, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of a Fixed Dose Combination of Dapagliflozin and Pioglitazone in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin Monotherapy
  Nilakshi Deka, Sambit Das, Kirtikumar D. Modi, Arundhati Das Gupta, Mukulesh Gupta, Ajay Chhabra, Niroj Kumar Mishra, Manjunath Goroshi, Hemi Soneja, Sameer Agarwal, Biplab Mandal, Amarkant Amar, Santosh Saklecha, Hiren Prajapati, Sachin Negi
  International Journal of Diabetes and Technology.2026; 5(3): 146.     CrossRef
• Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines
  David Liang, Daniala L. Weir, Safana Thevasahayam, Vera H. M. Deneer, Arno Siebes, Helga Gardarsdottir
  British Journal of Clinical Pharmacology.2026;[Epub]     CrossRef
• Early combination therapy in type 2 diabetes: Rethinking initial treatment strategies
  Andrej Janez, Tanja Smid, Manfredi Rizzo, Tsvetalina Tankova
  Journal of Diabetes and its Complications.2026; 40(10): 109392.     CrossRef
• GDD, a first-in-class APPL1 activator, restores mitochondrial homeostasis and insulin sensitivity with regulation of LKB1-AMPK axis
  Hao Zheng, Ya-Ru Zhao, Xian-Yan Deng, Dan-Yu Huang, Fang-Qiong Qiu, Chang Yan, Shu-Ying Li, Jing Chen, Wan-Bin Song, Hui-Qing Lv, Ri-Hui Wu, Ligen Lin, Li-She Gan
  Phytomedicine.2026; 161: 158712.     CrossRef
• Beyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies
  Ji Yoon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2026; 50(5): 844.     CrossRef
• Ginsenoside Rb1 and berberine synergistically protect against type 2 diabetes mellitus via GDF15/HAMP pathway throughout the liver lobules: Insights from spatial transcriptomics analysis
  Rongfang Guo, Shuying Zhang, Anyao Li, Ping Zhang, Xin Peng, Xiaoyan Lu, Xiaohui Fan
  Pharmacological Research.2025; 215: 107711.     CrossRef
• Factors associated with prescription of modern antidiabetics in newly diagnosed patients with type 2 diabetes. a real-world data study in a Spanish region
  Irantzu Bengoa-Urrengoechea, Isabel Aguilar-Palacio, María José Rabanaque, María Jesús Lallana, Adriana Gamba Cabezas, Sara Malo
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study
  Ji Yoon Kim, Nam Hoon Kim, Jiyoon Lee, Dong-Hoon Kim, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2025; 11(7): 620.     CrossRef
• High-performance liquid chromatography method for simultaneous determination of the degradation products of metformin hydrochloride and vildagliptin
  Amra Demirović, Alija Uzunović, Anisa Veledar-Hamalukić
  European Journal of Pharmaceutical Sciences.2025; 214: 107268.     CrossRef
• Cyclic amines-modified metformin derivatives with enhanced glucose uptake activity
  Muhammad Fathiy Mutalabisin, Nor Akmalyati Sulong, Nader Ghaffari Khaligh, Vannajan Sanghiran Lee, Nurshamimi Nor Rashid, Mohd Rafie Johan, Chin Fei Chee
  Results in Chemistry.2025; 18: 102830.     CrossRef
• Beta-Cell Function, Insulin Sensitivity, and Metabolic Characteristics in Young-Onset Type 2 Diabetes Mellitus: Findings from Anam Diabetes Observational Study
  Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2025; 49(6): 1287.     CrossRef
• Anti-Senescence Effect of Inhibiting Sodium-Glucose Cotransporter 2 and α-Glucosidase in a Type 2 Diabetes Mellitus Animal Model
  Serin Hong, Byung Soo Kong, Hyunsuk Lee, Young Min Cho
  Diabetes & Metabolism Journal.2025; 49(6): 1229.     CrossRef
• Targeting adipose remodeling: Synergistic mechanisms of drugs and adipose-derived stem cells in obese type 2 diabetes mellitus
  Cheng Luo, Xian-Mei Yu, Liang-Yan Hua, Mei-Qi Zeng, Hui Xu, Cheng-Zheng Duan, Shi-Yu Xu, Da Sun, Li-Ya Ye, Dong-Juan He
  World Journal of Stem Cells.2025;[Epub]     CrossRef
• Balancing Bleeding and Ischemic Risks: A Systematic Review of Dual Versus Triple Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
  Abubakar Gapizov, Ahmad Mohammad, Shivam Singla, Bhavna Singla, Saifullah Syed, Sunita Kumawat, Zulqurnain Ali
  Cureus.2025;[Epub]     CrossRef
• GLYCEMIC CONTROL AND COMORBIDITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A GENDER-BASED STUDY IN HEALTH FACILITIES OF DUHOK, IRAQ
  Hozan Qasim Hussein, Hileen Mustafa Haji, Milat Hussein Mustafa
  Health Problems of Civilization.2025;[Epub]     CrossRef
• Vector of glycated hemoglobin in the formation of dysglycemia in postmenopause: Emphasis on early diagnosis and therapy
  L. A. Ruyatkina, D. S. Ruyatkin, L. V. Shcherbakova, I. S. Iskhakova
  Meditsinskiy sovet = Medical Council.2024; (16): 135.     CrossRef